1-6 of 6
Yu Fang
Close
Sort by
Journal Articles

Treatment Patterns in Patients with Mantle Cell Lymphoma: Updated Report of the Asia-Pacific Multinational Retrospective Registry Study

Hyungwoo Cho, Dok Hyun Yoon, Jason Yongsheng Chan, Dajung Kim, Haiwen Huang, Qingqing Cai, Yu Fang, Tongyu Lin, Koji Kato, Udomsak Bunworasate, Sen Mui Tan, Ka-Won Kang, Jae-Yong Kwak, Tsai-Yun Chen, Jeong-Ok Lee, Seong Hyun Jeong, Young Rok Do, Esther Hian Li Chan, Hye Jin Kang, Hyeon-Seok Eom, Sung Yong Oh, Youngil Koh, Hyo Jung Kim, Se Hyung Kim, Jong-Ho Won, Young Hoon Park, Deok-Hwan Yang, Soo Chin Ng, Jae-Cheol Jo, Won Seog Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 6638.
https://doi.org/10.1182/blood-2023-183100
Published: 2023
Journal Articles

Central Nervous System Involvement in Extranodal Natural Killer/T-Cell Lymphoma: Case Series

Qingqing Cai, Jinni Wang, Yu Fang, Ning Su, Shuyun Ma, Jun Cai, Yuchen Zhang, Xiaopeng Tian, Huiqiang Huang, Zhiming Li, He Huang, Yi Xia, Panpan Liu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1399.
https://doi.org/10.1182/blood-2021-150205
Published: 2021
Journal Articles

Synergistic Antitumor Effect and Mechanism of Chidamide Combined with Gemcitabine, Oxaliplatin or Zanubrutinib in Diffuse Large B-Cell Lymphoma

Qingqing Cai, PhD, Tianying Huang, Master, Ning Su, MM, Xiaolu Xu, Master, Fengwei Wang, Doctor, Yu Fang, BMBS, Xiaopeng Tian, MDPhD, Jun Cai, BMBS, Shuyun Ma, MM, Yang Liang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-133487
Published: 2020
Journal Articles

The Expression of Paks and Its Clinical Significance in T-Cell Lymphoblastic Lymphoma

Qingqing Cai, PhD, Ning Su, MM, Yu Fang, BMBS, Xu Chen, MDPhD, Xiaopeng Tian, MDPhD, Shuyun Ma, MM, Xiaoqin Chen, MDPhD, Zhongjun Xia, MDPhD, Tongyu Lin, MD PhD, Huiqiang Huang, MDPhD, Zhiming Li, MD PhD, Xueyi Pan, MDPhD, Yi Xia, MD PhD, Panpan Liu, MD PhD, Xuanye Zhang, MDPhD, Hang Yang, MD PhD, Stephen Yang Liang, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–16.
https://doi.org/10.1182/blood-2020-136975
Published: 2020
Journal Articles

Safety and Preliminary Efficacy of Sintilimab Plus P-Gemox (Pegaspargase, Gemcitabine and Oxaliplatin) Regimen As First-Line Treatment for Patients with Advanced Extranodal Natural Killer/T Cell Lymphoma, Nasal Type: An Open-Label, Multicenter, Phase 2 Study

Qingqing Cai, PhD, Huiqiang Huang, MDPhD, Panpan Liu, MD PhD, Hui Zhou, MD PhD, Yajun Li, MD PhD, Yujing Zhang, MD PhD, Lixia Lu, MD PhD, Yan Gao, MD PhD, Xuanye Zhang, MDPhD, Yi Xia, MD PhD, Jun Cai, BMBS, Ning Su, MM, Shuyun Ma, MM, Hang Yang, MD PhD, Yu Fang, BMBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-136949
Published: 2020
Journal Articles

Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia

Hsin-Yu Fang, Russell Hughes, Craig Murdoch, Seth B. Coffelt, Subhra K. Biswas, Adrian L. Harris, Randall S. Johnson, Hongxia Z. Imityaz, M. Celeste Simon, Erik Fredlund, Florian R. Greten, Jordi Rius, Claire E. Lewis
Journal: Blood
Blood (2009) 114 (4): 844–859.
https://doi.org/10.1182/blood-2008-12-195941
Published: 2009